Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

Please share Science & Enterprise

Grant Funds Regenerative Gel for Treating Skin Ulcers

Antoni Ribas

A California state research agency is funding preclinical development of a gel designed to regenerate stem cells in the skin to help heal venous skin ulcers. . . . → Read More: Grant Funds Regenerative Gel for Treating Skin Ulcers

Hydrogel Biomaterials Company Raises $3M in Early Funds

Trivia Frazier

A developer of bioactive hydrogels as alternatives to animal models for drug discovery and clinical lab tests is raising $3 million in its first venture round. . . . → Read More: Hydrogel Biomaterials Company Raises $3M in Early Funds

RNA Cancer Immunotherapy Shown Feasible in Preclinical Test

Lung cancer illustration

Tests with lab animals show synthetic viral RNA particles, encased in natural oils, can safely invoke an immune response to attack solid tumors. . . . → Read More: RNA Cancer Immunotherapy Shown Feasible in Preclinical Test

Nasal Spray Vaccines Get CEPI, NIH Funding

Nasal spray

A developer of infectious disease vaccines is gaining funds for new nasal sprays protecting against a range of coronaviruses and the sexually-transmitted disease gonorrhea. . . . → Read More: Nasal Spray Vaccines Get CEPI, NIH Funding

Algae-Grown Non-Needle Malaria Vaccine in Preclinical Test

Malaria clinic

A vaccine grown in genetically-altered algae, designed as a nasal-spray and edible drug, is shown to protect lab mice against parasite infections causing malaria. . . . → Read More: Algae-Grown Non-Needle Malaria Vaccine in Preclinical Test

Company Formed to Boost Clinical Trial Success Odds

Human machine interface

A pharma/tech industry group is starting a new company to use algorithms for finding gaps in preclinical data that can impair clinical trial progress. . . . → Read More: Company Formed to Boost Clinical Trial Success Odds

Challenge Seeks Animal-Free Testing for Precision Meds.

Bioprinting

A charitable foundation promoting research on human longevity unveiled a challenge competition to develop animal-free testing for personalized medicine. . . . → Read More: Challenge Seeks Animal-Free Testing for Precision Meds.

Cell, mRNA Therapy Biotech Raises $165M in Early Funds

T-cells illustration

A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body. . . . → Read More: Cell, mRNA Therapy Biotech Raises $165M in Early Funds

Peptide Vaccine Shown to Reduce Harmful Cholesterol

Heart, circulation system

Tests with lab monkeys show a vaccine with a synthetic peptide lowers so-called bad cholesterol in blood for longer periods than a comparable monoclonal antibody. . . . → Read More: Peptide Vaccine Shown to Reduce Harmful Cholesterol

Biotech Start-Up Demonstrates Cancer Therapy, Raises $6.4M

DNA puzzle

A new biotechnology company demonstrated in lab mice its therapy for glioblastoma, an aggressive brain cancer, that overcomes limitations of current treatments. . . . → Read More: Biotech Start-Up Demonstrates Cancer Therapy, Raises $6.4M